Miltefosine

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1574 publications

Lem3, a phospholipid flippase subunit, influences Candida albicans pathogenicity through maintenance of plasma membrane asymmetry.

Lem3, a phospholipid flippase subunit, influences Candida albicans pathogenicity through maintenance of plasma membrane asymmetry.

Journal: Microbiology spectrum
Published: March 31, 2026

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin.

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin.

Journal: International journal of molecular sciences
Published: February 25, 2026

New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance.

New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance.

Journal: Journal of fungi (Basel, Switzerland)
Published: February 20, 2026

Microbiological Profile of Meningoencephalitis Due to Pathogenic Free-Living Amoebae: A Case Series From Kerala, India.

Microbiological Profile of Meningoencephalitis Due to Pathogenic Free-Living Amoebae: A Case Series From Kerala, India.

Journal: Cureus
Published: February 19, 2026

Primary Amoebic Meningoencephalitis caused by Complement C2 Deficiency.

Primary Amoebic Meningoencephalitis caused by Complement C2 Deficiency.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

In vitro activity of gallium-protoporphyrin IX against Leishmania major and Leishmania infantum.

In vitro activity of gallium-protoporphyrin IX against Leishmania major and Leishmania infantum.

Journal: Microbiology spectrum
Published: January 30, 2026

Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights.

Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights.

Journal: Drug development research
Published: January 12, 2026

Exploring EGCG for Leishmaniasis: A Natural Strategy for Neglected Disease Intervention.

Exploring EGCG for Leishmaniasis: A Natural Strategy for Neglected Disease Intervention.

Journal: The Yale journal of biology and medicine
Published: January 01, 2026

Tetronic® 1307-Based Polymeric Micelles and Thermoresponsive Gels for the Co-Delivery of Pentamidine and Miltefosine.

Tetronic® 1307-Based Polymeric Micelles and Thermoresponsive Gels for the Co-Delivery of Pentamidine and Miltefosine.

Journal: Pharmaceutics
Published: December 22, 2025

Econazole Exhibits In Vitro and In Vivo Efficacy Against Leishmania amazonensis.

Econazole Exhibits In Vitro and In Vivo Efficacy Against Leishmania amazonensis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 17, 2025

Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand.

Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand.

Journal: Tropical medicine and health
Published: December 10, 2025

New antifungals for the treatment of invasive mold disease.

New antifungals for the treatment of invasive mold disease.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: December 05, 2025
Showing 1-12 of 1,574

Last Updated: 04/28/2026